BRCA1/2 MUTATION

Clinical trials for BRCA1/2 MUTATION explained in plain language.

Never miss a new study

Get alerted when new BRCA1/2 MUTATION trials appear

Sign up with your email to follow new studies for BRCA1/2 MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

First-of-its-Kind vaccine aims to stop cancer before it starts in High-Risk individuals

Prevention Ongoing

This early-stage study is testing an experimental vaccine designed to potentially prevent cancer in people who carry BRCA1 or BRCA2 gene mutations, which significantly increase cancer risk. The research will enroll 44 adult participants, including both cancer survivors and health…

Matched conditions: BRCA1/2 MUTATION

Phase: PHASE1 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Prevention

Last updated Mar 25, 2026 14:09 UTC

BRCA1/2 MUTATION

Get alerted when new BRCA1/2 MUTATION trials appear

First-of-its-Kind vaccine aims to stop cancer before it starts in High-Risk individuals